Lacey E. Dobrolecki Department of Molecular and Cellular Biology Baylor College of Medicine Biography Publications Institution JoVE Articles Lacey E. Dobrolecki has not added a biography. If you are Lacey E. Dobrolecki and would like to personalize this page please email our Author Liaison for assistance. Publications A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer Journal of Clinical Medicine. 10, 2019 | Pubmed ID: 31652963 The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models Molecular Cancer Research : MCR. 10, 2019 | Pubmed ID: 31320385 Chromosome 12p Amplification in Triple-Negative/Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity Cancer Research. 08, 2019 | Pubmed ID: 31213465 Circulating Tumor Cell Investigation in Breast Cancer Patient-derived Xenograft Models by Automated Immunofluorescence Staining, Image Acquisition, and Single Cell Retrieval and Analysis BMC Cancer. Mar, 2019 | Pubmed ID: 30871481 C/EBPδ Links IL-6 and HIF-1 Signaling to Promote Breast Cancer Stem Cell-associated Phenotypes Oncogene. 05, 2019 | Pubmed ID: 30262865 Differentiation-state Plasticity is a Targetable Resistance Mechanism in Basal-like Breast Cancer Nature Communications. 09, 2018 | Pubmed ID: 30232459 Combinatorial Inhibition of PTPN12-regulated Receptors Leads to a Broadly Effective Therapeutic Strategy in Triple-negative Breast Cancer Nature Medicine. 05, 2018 | Pubmed ID: 29578538 Pharmacological Targeting of MYC-regulated IRE1/XBP1 Pathway Suppresses MYC-driven Breast Cancer The Journal of Clinical Investigation. 04, 2018 | Pubmed ID: 29480818 Carbon Nanotube Capsules Enhance the in Vivo Efficacy of Cisplatin Acta Biomaterialia. 08, 2017 | Pubmed ID: 28465075 Mutual Regulation of Tumour Vessel Normalization and Immunostimulatory Reprogramming Nature. 04, 2017 | Pubmed ID: 28371798 Patient-derived Xenograft (PDX) Models in Basic and Translational Breast Cancer Research Cancer Metastasis Reviews. 12, 2016 | Pubmed ID: 28025748 Oncogenic MTOR Signalling Recruits Myeloid-derived Suppressor Cells to Promote Tumour Initiation Nature Cell Biology. Jun, 2016 | Pubmed ID: 27183469 Antitumor Activity of Cetuximab in Combination with Ixabepilone on Triple Negative Breast Cancer Stem Cells Breast Cancer Research : BCR. Jan, 2016 | Pubmed ID: 26757880 Circulating and Disseminated Tumor Cells from Breast Cancer Patient-derived Xenograft-bearing Mice As a Novel Model to Study Metastasis Breast Cancer Research : BCR. 2015 | Pubmed ID: 25572662 A Peptide Mimicking a Region in Proliferating Cell Nuclear Antigen Specific to Key Protein Interactions is Cytotoxic to Breast Cancer Molecular Pharmacology. Feb, 2015 | Pubmed ID: 25480843 Drug-repositioning Screening Identified Piperlongumine As a Direct STAT3 Inhibitor with Potent Activity Against Breast Cancer Oncogene. Mar, 2015 | Pubmed ID: 24681959 Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy Journal of Biomolecular Screening. Jul, 2014 | Pubmed ID: 24525869 A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-derived Human Breast Cancer Xenograft Models Cancer Research. Aug, 2013 | Pubmed ID: 23737486 Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-initiating Cells and Improves Recurrence Free Survival in a Human-xenograft Model PloS One. 2012 | Pubmed ID: 22879872 Trasplante ortotópico de tumores de mama como modelos preclínicos para el cáncer de mama Xiangdong Lv*1,2,3, Lacey E. Dobrolecki*1,2,3, Yao Ding1,2,3, Jeffrey M. Rosen1,2,3, Michael T. Lewis1,2,3, Xi Chen1,2,3 1Department of Molecular and Cellular Biology, Baylor College of Medicine, 2Lester and Sue Smith Breast Center, Baylor College of Medicine, 3Dan L. Duncan Cancer Center, Baylor College of Medicine JoVE 61173 Pesquisa do câncer
Trasplante ortotópico de tumores de mama como modelos preclínicos para el cáncer de mama Xiangdong Lv*1,2,3, Lacey E. Dobrolecki*1,2,3, Yao Ding1,2,3, Jeffrey M. Rosen1,2,3, Michael T. Lewis1,2,3, Xi Chen1,2,3 1Department of Molecular and Cellular Biology, Baylor College of Medicine, 2Lester and Sue Smith Breast Center, Baylor College of Medicine, 3Dan L. Duncan Cancer Center, Baylor College of Medicine JoVE 61173 Pesquisa do câncer